**Headline:** Majority Support Maintaining Strong Impact Assessments and Consultations in Better Regulation Review

**Headline:** Majority Support Maintaining Strong Impact Assessments and Consultations in Better Regulation Review

The European Commission concluded its Better Regulation consultation on February 4, receiving 286 responses. Most participants emphasized the importance of preserving robust impact assessments and consultation mechanisms in the regulatory process. Respondents cautioned against prioritizing speed over transparency, highlighting that thorough analysis and stakeholder engagement are essential for effective and …

Read more

**Headline:** Ultragenyx Pharmaceutical Investors May Join Class Action Over Setrusumab Trial Claims

QwikNewz.com

Ultragenyx Pharmaceutical Inc. is facing a potential class action lawsuit after allegations that the company provided misleading information regarding the likelihood of success for its Phase 3 study of setrusumab in reducing fracture rates. Investors who experienced significant losses related to these claims are being invited to participate and possibly …

Read more

**Headline:** CFTC Expands Eligibility for Stablecoin Issuers to Include National Trust Banks

**Headline:** CFTC Expands Eligibility for Stablecoin Issuers to Include National Trust Banks

The Commodity Futures Trading Commission (CFTC) has updated its guidance to recognize national trust banks as eligible issuers of payment stablecoins. This change extends the range of institutions authorized to issue stablecoins beyond the previously recognized traditional banks. By broadening the list of eligible issuers, the CFTC aims to provide …

Read more

**Ukraine Receives 300 Generators Through SECI Support**

**Ukraine Receives 300 Generators Through SECI Support**

Ukraine has received 300 generators as part of assistance provided by the South-East European Cooperation Initiative (SECI). The delivery was confirmed by Ukraine’s Deputy Prime Minister for Restoration and Minister for Development of Communities and Territories via a Telegram post. The generators are intended to support Ukraine’s ongoing efforts to …

Read more

**Headline:** Roche’s fenebrutinib shows promise in slowing disability progression in primary progressive multiple sclerosis

QwikNewz.com

Roche has released new data from its Phase III FENtrepid trial demonstrating that fenebrutinib, an investigational Bruton’s tyrosine kinase (BTK) inhibitor, met its primary goal of being at least as effective as ocrelizumab (Ocrevus) in reducing disability progression in patients with primary progressive multiple sclerosis (PPMS). The study showed a …

Read more

**Headline:** Rosen Law Firm Announces Class Action Lawsuit for Mereo BioPharma Group plc Investors, Sets April 6 Deadline for Lead Plaintiff Applications

QwikNewz.com

Rosen Law Firm has filed a securities class action lawsuit on behalf of investors who purchased American Depositary Shares (ADS) of Mereo BioPharma Group plc (NASDAQ: MREO) between June 5, 2023, and December 26, 2025. Investors interested in serving as lead plaintiff must file a motion with the court by …

Read more